Cargando…
Stanniocalcin 1 is a prognostic biomarker in glioma
Malignant gliomas are the most common type of primary malignancy of the central nervous system with a poor prognosis. Stanniocalcin 1 (STC1) is closely associated with tumor genesis and development. However, its role in the development and progression of glioma is poorly understood. In silico analys...
Autores principales: | Luo, Weijian, Chen, Dong, Wang, Hao, Hu, Jiliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400771/ https://www.ncbi.nlm.nih.gov/pubmed/32782542 http://dx.doi.org/10.3892/ol.2020.11792 |
Ejemplares similares
-
Early-stage serum Stanniocalcin 1 as a predictor of outcome in patients with aneurysmal subarachnoid hemorrhage
por: Jun, Qin, et al.
Publicado: (2021) -
Expression of Stanniocalcin-1 and Stanniocalcin-2 in Laryngeal Squamous Cell Carcinoma and Correlations with Clinical and Pathological Parameters
por: Zhou, Han, et al.
Publicado: (2014) -
Stanniocalcin2, but Not Stanniocalcin1, Responds to Hypoxia in a HIF1-Dependent Manner in the Retina
por: Ail, Divya, et al.
Publicado: (2022) -
Expression and Prognostic Role of PLOD1 in Malignant Glioma
por: Wang, Hao, et al.
Publicado: (2020) -
Role of stanniocalcin-1 in breast cancer
por: Chen, Fengxia, et al.
Publicado: (2019)